jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Lip biopsy - Medium Biopsy 1-3 cm

Biopsy
image

Report in 288Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Biopsy of lip tissue.

370529

30% OFF

Lip Biopsy - Medium Biopsy 1-3 cm

  • Why is it done?
    • Test Purpose: A lip biopsy is a tissue sampling procedure used to obtain a sample of lip tissue for histopathological examination and diagnosis of suspected abnormalities.
    • Primary Indications: Diagnosis of suspicious lesions, tumors, or growths on the lip; evaluation of chronic lip conditions; suspected malignancy or pre-malignant lesions; persistent ulcerations or sores; atypical pigmentation or discoloration; evaluation of systemic diseases affecting the lip (such as sarcoidosis or systemic sclerosis).
    • Clinical Circumstances: Performed when visible lip lesions show concerning features such as irregular borders, color variation, bleeding, or failure to heal; typically performed when imaging or clinical examination cannot definitively establish diagnosis; arranged urgently when malignancy is suspected.
  • Normal Range
    • Normal Result Interpretation: Benign findings with normal histology showing typical stratified squamous epithelium with intact epithelial-dermal interface; no evidence of malignancy, dysplasia, inflammation, or unusual cellular growth.
    • Reference Findings (Normal): Intact oral mucosa structure; uniform epithelial maturation; normal melanin distribution; appropriate inflammatory response (if any); normal vascular pattern; absence of atypical cells or malignant features.
    • Interpretation Categories: Results are typically reported as 'Benign' (normal), 'Dysplasia' (low-grade or high-grade), 'Malignant' (cancerous), or 'Inconclusive' (requiring additional staining or repeat biopsy).
    • Units of Measurement: Qualitative descriptive pathology report; microscopic examination at 4x, 10x, 20x, and 40x magnifications; immunohistochemical markers assessed as positive or negative.
  • Interpretation
    • Benign Findings: Normal histology, chronic inflammation, infection, traumatic lesion, or reactive hyperplasia; indicates no malignancy present; generally requires clinical follow-up based on initial presentation.
    • Low-Grade Dysplasia: Abnormal cell maturation primarily in lower epithelial layers; slight to moderate architectural disarray; nuclei slightly enlarged with increased chromatin; represents early pre-malignant change; requires close monitoring and potential re-excision.
    • High-Grade Dysplasia: Severe cytologic atypia extending through multiple epithelial layers; increased nuclear-to-cytoplasmic ratio; hyperchromatic nuclei; abnormal mitotic figures; significant risk of progression to malignancy; requires urgent surgical intervention and frequent monitoring.
    • Squamous Cell Carcinoma: Malignant epithelial tumor showing infiltrating nests of atypical squamous cells; invasive growth pattern into underlying tissues; confirmed malignancy requiring immediate oncologic consultation and staging.
    • Melanoma or Other Malignancy: Primary or metastatic malignant melanoma or other cancers; requires urgent oncologic evaluation, staging studies, and treatment planning.
    • Systemic Disease Features: Granulomatous inflammation (sarcoidosis), collagen deposition (systemic sclerosis), vasculitis, or other systemic findings; requires correlation with clinical presentation and additional investigations.
    • Factors Affecting Results: Tissue fixation quality; biopsy site representation (peripheral vs. central location); specimen crush artifact; prior radiation or chemotherapy; smoking history; HPV status; immunocompromised state; oral hygiene factors.
  • Associated Organs
    • Primary Organ System: Integumentary and mucosal tissue (lips are modified skin with underlying mucosa); oral cavity and facial structures; lymphatic drainage to cervical and submandibular lymph nodes.
    • Diseases This Test Diagnoses: Squamous cell carcinoma (SCC); basal cell carcinoma; melanoma; actinic cheilitis (solar cheilitis); oral lichen planus; pemphigus vulgaris; erosive lichen planus; oral lichenoid contact reactions; sarcoidosis; systemic lupus erythematosus (SLE); scleroderma; leukoplakia; erythroplakia; verrucous carcinoma.
    • Associated Anatomical Structures: Vermillion border; oral commissure; gingivae; buccal mucosa; tongue; surrounding facial skin; mandibular and maxillary structures.
    • Potential Complications: Malignancy with local invasion and regional lymph node involvement; metastatic potential to distant organs; need for more extensive surgical intervention; cosmetic and functional impact; infection if malignancy involves deeper tissues; involvement of sensory or motor nerves.
    • Lymphatic Drainage Significance: Lip lesions drain to submandibular, submental, and cervical lymph nodes; malignancy may require nodal staging and assessment.
  • Follow-up Tests
    • If Benign Result: Clinical follow-up in 2-4 weeks; repeat biopsy if lesion persists or changes; no additional imaging unless clinically indicated; patient education on sun protection and lesion monitoring.
    • If Dysplasia Detected: Repeat biopsy or complete excision with wider margins; close clinical surveillance every 3-6 months; repeat biopsies at 6-12 month intervals if conservative management chosen; photographic documentation of lesion; consider dermatology or otolaryngology referral.
    • If Malignancy Confirmed: Urgent surgical oncology consultation; wide local excision with appropriate margins; imaging studies (CT or MRI) for staging; ultrasound or CT of regional lymph nodes; consider PET-CT for advanced disease; tumor marker studies if indicated.
    • Complementary Diagnostic Tests: Immunohistochemistry (p16, p53, Ki-67) for HPV status and dysplasia grading; special stains (melanin, iron, elastic) based on histologic features; molecular testing for specific mutations; HPV PCR testing if indicated.
    • Systemic Disease Workup: If granulomatous inflammation (sarcoidosis), perform chest X-ray, ACE level, calcium level; if autoimmune findings (SLE, scleroderma), order ANA, rheumatoid factor, anti-Scl-70 antibodies; direct immunofluorescence for pemphigus/pemphigoid.
    • Monitoring Schedule: Benign: Annual clinical examination; Dysplasia: Every 3-6 months for 2 years, then annual; Malignancy: Staging immediately, then follow-up per oncology protocol (typically every 3-6 months for 2 years, then annually).
  • Fasting Required?
    • Fasting Requirement: No - Fasting is NOT required for lip biopsy. This is a local tissue sampling procedure.
    • Pre-Procedure Preparation: Patient may eat and drink normally before procedure; light meal or liquid 1-2 hours before is acceptable; arrive well-hydrated; normal morning routine permitted.
    • Medications to Avoid: Discontinue anticoagulants (warfarin, apixaban) 3-5 days prior if possible (consult prescribing physician); discontinue antiplatelet agents (aspirin, NSAIDs, clopidogrel) 5-7 days before if safe to do so; stop over-the-counter blood thinners and herbal supplements (ginger, garlic, ginkgo biloba) 3-5 days before.
    • Pre-Biopsy Instructions: Clean the area gently with warm water; avoid heavy makeup or cosmetics on lips day of procedure; brush teeth gently; avoid sharp or hard foods that might irritate the lip; wear loose, comfortable clothing; arrange transportation if sedation planned.
    • Anesthesia Considerations: Local anesthesia (lidocaine) administered at biopsy site; minimal systemic absorption for typical 1-3 cm biopsy; no general anesthesia required for medium biopsy unless patient preference or anxiety.
    • Post-Procedure Care: Can eat soft foods after anesthesia wears off (1-2 hours); avoid hot foods/beverages for 24 hours; avoid alcohol, smoking, and vigorous rinsing for 24 hours; apply ice packs intermittently for swelling; take over-the-counter pain relief as needed; keep area clean and dry.
    • Reporting Complications: Contact provider if excessive bleeding, severe pain, signs of infection (increased warmth, redness, pus), difficulty swallowing, or fever develops; most minor bleeding and discomfort resolve within 3-5 days.

How our test process works!

customers
customers